Ancriviroc

370893-06-4

Ancriviroc

Methanone, (4-bromophenyl)[1′-[(2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4′-methyl[1,4′-bipiperidin]-4-yl]-, O-ethyloxime, (Z)-

{4-[(Z)-(4-Bromophenyl)(ethoxyimino)methyl]-4′-methyl-1,4′-bipiperidin-1′-yl}(2,4-dimethyl-1-oxido-3-pyridinyl)methanone

{4-[(Z)-(4-bromophenyl)(ethoxyimino)methyl]-4′-methyl-1,4′-bipiperidin-1′-yl}(2,4-dimethyl-1-oxidopyridin-3-yl)methanone

{4-[(Z)-(4-Bromophényl)(éthoxyimino)méthyl]-4′-méthyl-1,4′-bipipéridin-1′-yl}(2,4-diméthyl-1-oxydo-3-pyridinyl)méthanone

{4-[(Z)-(4-Bromphenyl)(ethoxyimino)methyl]-4′-methyl-1,4′-bipiperidin-1′-yl}(2,4-dimethyl-1-oxido-3-pyridinyl)methanon

(2,4-Dimethyl-1-oxy-pyridin-3-yl)-(4′-methyl-[1,4′]bipiperidinyl-1′-yl)-methanone

(4-{(4-Bromo-phenyl)-[(Z)-ethoxyimino]-methyl}-4′-methyl-[1,4′]bipiperidinyl-1′-yl)-(2,4-dimethyl-1-oxy-pyridin-3-yl)-methanone

(4-{(4-Bromo-phenyl)-[(Z)-ethoxyimino]-methyl}-4″-methyl-[1,4″]bipiperidinyl-1″-yl)-(2,4-dimethyl-1-oxy-pyridin-3-yl)-methanone

1′-[(2,4-Dimethyl-1-oxidopyridin-3-yl)carbonyl]-4′-methyl-1,4′-bipiperidine

3-[(4-{4-[(1Z)-(4-bromophenyl)(ethoxyimino)methyl]piperidin-1-yl}-4-methylpiperidin-1-yl)carbonyl]-2,4-dimethylpyridin-1-ium-1-olate

305792-46-5

4-((4-bromophenyl)-(ethoxyimino)methyl)-1′-((2,4-dimethyl-3-pyridinyl)carbonyl)-4′-methyl-1,4′-bipiperidine N-oxide

4-[4-[C-(4-BROMOPHENYL)-N-ETHOXY-CARBONIMIDOYL]-PIPERIDIN-1-YL]-4-METHYL-PIPERIDIN-1-YL]-(2,4-DIMETHYL-1-OXIDO-(PYRIDIN-3-YL))METHANONE

[4-[4-[(Z)-(4-bromophenyl)-ethoxyiminomethyl]-1-piperidinyl]-4-methyl-1-piperidinyl]-(2,4-dimethyl-1-oxido-3-pyridin-1-iumyl)methanone

[4-[4-[(Z)-C-(4-bromophenyl)-N-ethoxycarbonimidoyl]piperidin-1-yl]-4-methylpiperidin-1-yl]-(2,4-dimethyl-1-oxidopyridin-1-ium-3-yl)methanone

[³H]ancriviroc

[³H]SCH 351125

[³H]Sch-351125

AK671/SCH-C

ancrivirocum

Methanone, (4-bromophenyl)(1′-((2,4-dimethyl-3-pyridinyl)carbonyl)-4′-methyl(1,4′-bipiperidin)-4-yl)-, O-ethyloxime, (Z)-, N1-oxide & AOP-RANTES

Methanone, (4-bromophenyl)(1′-((2,4-dimethyl-3-pyridinyl)carbonyl)-4′-methyl(1,4′-pipiperidin)-4-yl)-, O-ethyloxime, N1-oxide

Methanone, (4-bromophenyl)[1′-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4′-methyl[1,4′-bipiperidin]-4-yl]-, O-ethyloxime, (Z)-, N1-oxide

Methanone, (4-bromophenyl)[1′-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4′-methyl[1,4′-bipiperidin]-4-yl]-, O-ethyloxime, (Z)-, N1-oxide & AOP-RANTES

Methanone, (4-bromophenyl)[1′-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4′-methyl[1,4′-bipiperidin]-4-yl]-, O-ethyloxime, (Z)-, N1-oxide & PRO 140 (Anti-CCR5 monoclonal antibody)

SCH 351125 & AOP-RANTES

SCH 351125 (non-stereospecific)

SCH C

SCH-C

SCH-C & AOP-RANTES

SCH-C cpd

SCH-C+PA14

{4-[(4-Bromo-phenyl)-ethoxyimino-methyl]-4′-methyl-[1,4′]bipiperidinyl-1′-yl}-(2,4-dimethyl-1-oxy-pyridin-3-yl)-methanone

анкривирок

أنكريفيروك

安立韦克